|
Volumn 342, Issue 8, 2009, Pages 462-468
|
Benzothiazole incorporated barbituric acid derivatives: Synthesis and anticonvulsant screening
|
Author keywords
Anticonvulsants; Barbituric acid; Benzothiazole; Pyrimidinetriones
|
Indexed keywords
1 (2 METHOXYPHENYL) 3 (6 NITRO 1,3 BENZOTHIAZOL 2 YL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (2 METHYLPHENYL) 3 (6 NITRO 1,3 BENZOTHIAZOL 2 YL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (4 METHOXYPHENYL) 3 (6 NITRO 1,3 BENZOTHIAZOL 2 YL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (4 METHYLPHENYL) 3 (6 NITRO 1,3 BENZOTHIAZOL 2 YL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 BROMO 1,3 BENZOTHIAZOL 2 YL) 3 (2 METHOXYPHENYL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 BROMO 1,3 BENZOTHIAZOL 2 YL) 3 (2 METHYLPHENYL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 BROMO 1,3 BENZOTHIAZOL 2 YL) 3 (4 METHOXYPHENYL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 BROMO 1,3 BENZOTHIAZOL 2 YL) 3 (4 METHYLPHENYL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 BROMO 1,3 BENZOTHIAZOL 2 YL) 3 PHENYLHEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 CHLORO 1,3 BENZOTHIAZOL 2 YL) 3 (2 METHOXYPHENY)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 CHLORO 1,3 BENZOTHIAZOL 2 YL) 3 (2 METHYLPHENYL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 CHLORO 1,3 BENZOTHIAZOL 2 YL) 3 (4 METHOXYPHENY)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 CHLORO 1,3 BENZOTHIAZOL 2 YL) 3 (4 METHYLPHENYL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 CHLORO 1,3 BENZOTHIAZOL 2 YL) 3 PHENYLHEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 FLUORO 1,3 BENZOTHIAZOL 2 YL) 3 (2 METHOXYPHENYL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 FLUORO 1,3 BENZOTHIAZOL 2 YL) 3 (2 METHYLPHENYL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 FLUORO 1,3 BENZOTHIAZOL 2 YL) 3 (4 METHOXYPHENYL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 FLUORO 1,3 BENZOTHIAZOL 2 YL) 3 (4 METHYLPHENYL)HEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 FLUORO 1,3 BENZOTHIAZOL 2 YL) 3 PHENYLHEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
1 (6 NITRO 1,3 BENZOTHIAZOL 2 YL) 3 PHENYLHEXAHYDRO 2,4,6 PYRIMIDINETRIONE;
ANILINE DERIVATIVE;
ANTICONVULSIVE AGENT;
BARBITURIC ACID DERIVATIVE;
BENZOTHIAZOLE DERIVATIVE;
CARBAMAZEPINE;
ETHOSUXIMIDE;
PENTETRAZOLE;
PHENOBARBITAL;
PHENYTOIN;
UNCLASSIFIED DRUG;
VALPROIC ACID;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTICONVULSANT ACTIVITY;
ARTICLE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SAFETY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ELECTRIC SHOCK;
LIPOPHILICITY;
MOTOR DYSFUNCTION;
MOUSE;
NONHUMAN;
PHARMACOPHORE;
PRIORITY JOURNAL;
SEIZURE;
STRUCTURE ANALYSIS;
ANILINE COMPOUNDS;
ANIMALS;
ANTICONVULSANTS;
BARBITURATES;
BENZOTHIAZOLES;
BINDING SITES;
DRUG EVALUATION, PRECLINICAL;
ELECTROSHOCK;
MICE;
MOTOR ACTIVITY;
PENTYLENETETRAZOLE;
SEIZURES;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 68249132797
PISSN: 03656233
EISSN: 15214184
Source Type: Journal
DOI: 10.1002/ardp.200900002 Document Type: Article |
Times cited : (28)
|
References (20)
|